SCHEMBL19732045

SCHEMBL19732045

c1ccc(-c2ccccc2-c2ccccc2-c2ccc(-c3ccc(N(c4ccc(-c5ccc(C6(c7ccccc7)c7ccccc7-c7ccccc76)cc5)cc4)c4ccc(-c5ccc(C6(c7ccccc7)c7ccccc7-c7ccccc76)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 3/20 0.46
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
OPRK1 P41145 1/20 0.46
POLB P06746 1/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
PDK2 Q15119 1/20 0.35
TDP1 Q9NUW8 2/20 0.33
THRB P10828 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816632 0.97 MEN1 (0.49) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL17816704 0.97 MEN1 (0.49) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL23079433 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL12978428 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL12978453 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL23079515 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL12978469 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL12978438 0.95 MEN1 (0.50) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL1784130 0.94 MEN1 (0.49) MEN1KMT2AMAPTLMNAKDM4E
SCHEMBL283098 0.94 MEN1 (0.49) MEN1KMT2AMAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170365782-A1 FLUORENE DERIVATIVE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365782-A1 FLUORENE DERIVATIVE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE NR2E3, NR2E1, AFF1 MEN1 1141/4885KMT2A 753/4885MAPT 3834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.